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NLRP3 inﬂammasome plays a critical role in the activation of caspase-1 and maturation of IL-1b.
However, the speciﬁc cis- and trans-regulatory elements that determine the extent of NLRP3 expres-
sion are not well deﬁned. In this study, we found NLRP3 expression was induced by TLR agonists in
murine macrophages in a NF-jB dependent manner. Furthermore, the corresponding NF-jB bind-
ing sites (nt 1303 to 1292 and 1238 to 1228) were identiﬁed in the NLRP3 promoter. Finally,
EMSA and ChIP assays demonstrated LPS-induced NF-jB binding to the NLRP3 promoter. Therefore,
out results delineated the molecular mechanisms involved in TLR-induced transcriptional regula-
tion of NLRP3.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
NLRP3 (also known as NALP3, Cryopyrin, CIAS1, PYPAF1 and
CLR1.1) is a member of the Nod-like receptor (NLR) family of intra-
cellular pattern-recognition molecules detecting microbial- and
danger-associated molecular patterns [1,2]. NLRP3 and other NLR
proteins such as NLRP1 and NLRP4 play a critical role in the activa-
tion of caspase-1-containing complexes, also known as inﬂamma-
somes [3]. Upon detecting cellular stress, NLRP3 oligomerizes and
exposes its effector domain for interaction with the adaptor pro-
tein ASC (apoptosis-associated speck-like protein containing a cas-
pase recruitment domain), which in turn recruits pro-caspase-1,
leading to the activation of caspase-1 and cleavage of the pro-form
of interleukin-1b (IL-1b) and IL-18 into their mature forms [4]. Due
to its association with numerous inﬂammatory diseases, it has
drawn great attention in recent years [5–8]. Although the function
of NLRP3 on the activation of caspase-1 and maturation of IL-1b
and IL-18 are well deﬁned, the molecular mechanisms for the tran-
scriptional regulation of NLRP3 expression are not clear.
Toll-like receptors (TLRs) play a pivotal role in defense against
invading pathogens through the detection of pathogen-associatedchemical Societies. Published by E
NOD-LRRs containing pyrin
matin immunoprecipitation;
tide
nology, Shandong University
250012, PR China. Fax: +86molecular patterns (PAMPs) [9]. Recognition of PAMPs by TLRs in
innate immune cells initiates complicated signaling pathways
leading to the activation of several transcriptions factor including
NF-jB and AP-1, which are involved in the production of proin-
ﬂammatory cytokines, chemokines as well as varieties of regula-
tory genes [10].
In this study, we demonstrated that NLRP3 expression was
induced by TLR agonists in a NF-jB dependent manner. Further,
the NF-jB binding elements (nt 1303 to 1292 and 1238 to
1228) were identiﬁed in the NLRP3 promoter. LPS-induced NF-
jB binding to these sequences was conﬁrmed with EMSA and ChIP
assays.
2. Materials and methods
2.1. Mice and reagent
C57BL/6J mice were obtained from Joint Ventures Sipper BK
Experimental Animal (Shanghai, China). All animal experiments
were undertaken in accordancewith theNational Institute of Health
Guide for the Care and Use of Laboratory Animals, with the approval
of the Scientiﬁc Investigation Board of Shandong University, Jinan,
China. LPS (Escherichia coli, 055:B5), PGN (peptidoglycan) and JSH-
23 (4-methyl-N-benzene-1,2-diamine) were purchased from Sigma
(St. Louis, MO). Antibody speciﬁc to NLRP3 was obtained from Enzo
Life Science (ENZO, NY). Antibody speciﬁc to actin and horseradish
peroxidase-coupled secondary antibodies were obtained from San-
ta Cruz Biotechnology (Santa Cruz, CA).lsevier B.V. All rights reserved.
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Mouse primary peritoneal macrophages were prepared as de-
scribed [11]. RAW264.7 macrophage cell line was obtained from
ATCC (Manassas, VA). The cells were cultured at 37 C under 5%
CO2 in DMEM supplemented with 10% FCS (Invitrogen-Gibco),
100 U/ml penicillin, and 100 lg/ml streptomycin. LPS and PGN
were used at a ﬁnal concentration of 100 ng/ml and 10 lg/ml,
respectively.
2.3. RT-PCR analysis
Total RNA was extracted with TRIzol reagent according to the
manufacturer’s instructions (Invitrogen, CA). One microliter of
the cDNA mixture was subjected to the standard PCR reaction for
25 cycles using the following primer sets: NLRP3 50-GAGTTCTT
CGCTGCTATGT-30 (sense) and 50-ACCTTCACGTCTCGGTTC-30 (anti-
sense); mouse b-actin 50-TGTTACCAACTGGGAC-GACA-30 (sense)
and 50-CTGGGTCATCTTTTCACGGT-30 (antisense). PCR products
were resolved on 1.5% agarose gel and visualized with UV light
after being stained with ethidium bromide.
2.4. Immunoblotting
Cells were lysed with M-PER Protein Extraction reagent (Pierce,
Rockford, IL) supplemented with a protease inhibitor ‘mixture’;
protein concentrations in the extracts were measured with a
bicinchoninic acid assay (Pierce, Rockford, IL). Equal amounts of
extracts were separated by SDS–PAGE and transferred onto nitro-
cellulose membrane for immunoblot analysis as described previ-
ously [11].2.5. Construction of NLRP3 luciferase reporter plasmids
The NLRP3 (NT-096135) promoter fragments nt 3033 to +166,
2032 to +166, 1733 to +166, 1434 to +166, 1113 to +166,
834 to +166 were ampliﬁed by PCR using mouse genomic DNA
from RAW264.7 macrophages as template and inserted into the
KpnI and XhoI sites of the luciferase reporter plasmid pGL3-basic
vector (Promega), yielding the reporter constructs NLRP3(3033),
NLRP3(2032), NLRP3(1733), NLRP3(1434), NLRP3(1113),
NLRP3(834), respectively. The NLRP3 promoter fragments nt
2032 to 1434 and nt 1434 to 1113 were ampliﬁed by PCR
and inserted into the KpnI and XhoI sites of pGL3-basic vector, yield-
ing the reporter constructs NLRP3(2032/1434) and NLRP
3(1434/1113), respectively. In the NF-jB point mutants, the
two NF-jB binding sites (A: nt 1303 to 1292 and B: nt 1238
to1228) in theNLRP3(1434/1113) reporterwere replacedwith
a non-functional sequences by two-step PCR, yielding the reporter
constructs NLRP3(1434/1113) MutA, NLRP3(1434/1113)
MutB and NLRP3(1434/1113) MutAB, respectively. All con-
structs were conﬁrmed by DNA sequencing. The sequences of prim-
ers used are upon request.2.6. Transfection and luciferase assay
RAW264.7 macrophages was cotransfected with the mixture of
the indicated luciferase reporter plasmid and pRL-TK-Renilla lucif-
erase plasmid using lipofectamine 2000 transfection reagent
(Invitrogen). After 24 h, the cells were treated with TLR agonists
in selected instances. Luciferase activities were measured with a
Dual Luciferase Reporter Assay System (Promega) according to
the manufacturer’s instructions. Data are normalized for transfec-
tion efﬁciency by dividing ﬁreﬂy luciferase activity with that of
Renilla luciferase.2.7. Chromatin immunoprecipitation (ChIP) assay
Peritoneal macrophages were stimulated with 100 ng/ml LPS
for 1 h or unstimulated. Chromatin from macrophages was ﬁxed
and immunoprecipitated using the ChIP assay kit as recommended
by the manufacturer (Upstate Biotechnology, NY). The puriﬁed
chromatin was immunoprecipitated using 3 lg of anti-p65 or irrel-
evant antibody (anti-actin). The input fraction corresponded to 0.1
and 0.05% of the chromatin solution before immunoprecipitation.
After DNA puriﬁcation, the presence of the selected DNA sequence
was assessed by PCR. The primers were 50-GAGCCCTGAGGTTT
CACTTTTTCCCATTG-30 and 50-AGCTTGCATCACTGTCAAAGACGGATT
GG-30 for NLRP3 promoter (nt 1348 to 1183). PCR products
were resolved in 1.5% agarose gel and visualized with UV light after
being stained with ethidium bromide. The average size of the son-
icated DNA fragments subjected to immunoprecipitation was
500 bp as determined by ethidium bromide gel electrophoresis.
2.8. Electrophoretic mobility shift assays (EMSA)
EMSA experiments were performed as described previously
[12]. The NLRP3 oligonucleotide sequence (containing NF-jB bind-
ing site A) was 50-AGGCTTCTGCAGGGAACCCCCGGGAATTCT-30 (nt
1313 to 1284). In competitive binding assays, unlabeled oligo-
nucleotides were added at a 200-fold molar excess. In non-compet-
itive assays, unlabeled EBNA oligonucleotides were used.
Supershift assays were performed by preincubating nuclear ex-
tracts with NF-jB p65 antibody.
2.9. Statistical analysis
All data are presented as means ± S.D. of three or four experi-
ments. Analysis was performed using a Student’s t test. Values of
P < 0.05 were considered signiﬁcant.
3. Results
3.1. TLR agonists up-regulate NLRP3 expression in macrophages
In order to investigate the molecular mechanisms involved in
NLRP3 transcriptional regulation, we initially measured NLRP3
expression upon stimulation with TLR agonists in murine macro-
phages. Stimulation with LPS (TLR4 ligand) signiﬁcantly increased
the expression of bothNLRP3 steady statemRNA and protein in per-
itonealmacrophages (Fig. 1A). The expression of NLRP3 steady state
mRNA and protein was also induced by PGN (TLR2 ligand) in perito-
neal macrophages (Fig. 1B). To further conﬁrm TLR-induced NLRP3
expression in macrophages, a macrophages cell line RAW264.7 was
used. Similarly, the expression of both NLRP3 steady state mRNA
and protein was signiﬁcantly induced after stimulation with LPS
or PGN for indicated time periods in RAW264.7 macrophages
(Fig. 1C and D). All together, these data indicate that NLRP3 expres-
sion is induced by TLR agonists LPS and PGN in murine
macrophages.3.2. NF-jB activation is required for TLR-induced NLRP3 expression
The stimulation of TLR4 by LPS or TLR2 by PGN induces NF-jB
activation in macrophages, which plays a central role in the regu-
lation of the expression of various genes. To investigate the role of
NF-jB in LPS-induced and PGN-induced NLRP3 expression, the NF-
jB speciﬁc inhibitor JSH-23 was used in the setting of LPS- and
PGN-stimulated macrophages. As shown in Fig. 2A and B, pretreat-
ment with JSH-23 substantially attenuated LPS- or PGN-induced
expression of NLRP3 mRNA and protein in peritoneal macrophages.
Fig. 1. TLR agonists up-regulate NLRP3 expression in macrophages. (A and B) Mice peritoneal macrophages were stimulated with LPS (100 ng/ml) or PGN (10 lg/ml) for the
indicated time periods, the expression of NLRP3 mRNA and protein was measured by RT-PCR and immunoblotting, respectively. (C and D) RAW264.7 macrophages were
stimulated with LPS (100 ng/ml) or PGN (10 lg/ml) for the indicated time periods, the expression of NLRP3 mRNA and protein was measured by RT-PCR and immunoblotting,
respectively. Similar results were obtained in three independent experiments.
Fig. 2. NF-jB activation is required for TLR-induced NLRP3 expression. (A and B) Mice peritoneal macrophages were pretreated with DMSO or JSH-23 (30 lM) for 40 min,
then stimulated with LPS (100 ng/ml) or PGN (10 lg/ml) for the indicated time periods. Expression of NLRP3 mRNA and protein was examined by RT-PCR and
immunoblotting, respectively. (C and D) RAW264.7 macrophages were pretreated with DMSO or JSH-23 (30 lM) for 40 min, then stimulated with LPS (100 ng/ml) or PGN
(10 lg/ml) for the indicated time periods. Expression of NLRP3 mRNA and protein was examined by RT-PCR and immunoblotting, respectively. Similar results were obtained
in three independent experiments.
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mRNA and protein was also greatly inhibited with the treatment
of JSH-23 (Fig. 2C and D). These data suggest that TLR-induced
NF-jB activation is required for NLRP3 expression in macrophages.
3.3. Characterization of NLRP3 gene promoter
To localize the cis-elements responsible for LPS-induced NLRP3
expression, various luciferase reporters with different length of
NLRP3 promoter were constructed and transiently transfected into
RAW264.7 cells. As shown in Fig. 3A, LPS stimulation induced a
4-fold increase in luciferase activity in theNLRP3(3033) reporter,
indicating the NLRP3 promoter fragment from nt 3033 to +166
contains the cis-elements required for LPS-induced NLRP3 expres-
sion. Further deletion constructs demonstrated a 5-fold, 4-fold
and 3-fold increase in luciferase activity in NLRP3(2032), NLR
P3(1733) and NLRP3(1434) reporters, respectively. But, LPS-in-
duced luciferase activity was completely ablated in NLRP3(1113)
andNLRP3(834) reporters, indicating the cis-elements responsible
for LPS-induced NLRP3 expression are between nt 1434 and
1113.
To further conﬁrm the fragment from nt 1434 to 1113 is suf-
ﬁcient for LPS-induced NLRP3 expression, the NLRP3 promoter frag-
ment from nt 1434 to 1113 was cloned and inserted into pGL3
reporter. As a control, NLRP3 promoter fragment from nt 1434
to 2032 was also cloned and inserted into pGL3 reporter. These
two reporters were transiently transfected into RAW264.7 cells.
As shown in Fig. 3B, LPS signiﬁcantly increase the luciferase activity
of NLRP3(1434/1113) reporter, but not of NLRP3(1434/2032)
reporter. Taken together, these data suggest that the cis-elements
responsible for LPS-induced NLRP3 expression are located in the
NLRP3 promoter region from nt 1434 to 1113.3.4. Identiﬁcation of NF-jB binding sites in the NLRP3 promoter
In order to identify the NF-jB binding sites, the NLRP3 pro-
moter fragment from nt 1434 to 1113 was submitted to the
TRANSFAC 6.0 database to determine potential NF-jB binding
sites. This analysis identiﬁed two putative NF-jB binding se-
quences: AGGGAACCCCCG (A: nt 1303 to 1292) and
GGAAAATCCAT (B: nt 1238 to 1228). To conﬁrm the function
of these NF-jB binding sequences in LPS-induced NLRP3 expres-
sion, the NF-jB binding sequences were mutated in
NLRP3(1434/1113) reporter to give rise NLRP3(1434/1113)
MutA, NLRP3(1434/1113) MutB and NLRP3(1434/1113) Mu-
tAB reporters, respectively. These mutants were transiently trans-
fected into RAW264.7 macrophages. LPS-stimulation signiﬁcantly
increased the luciferase activity of NLRP3(1434/1113) reporter
(Fig. 4). Surprisingly, LPS could still induce luciferase activation
in NLRP3(1434/1113) MutA reporter, and LPS-induced lucifer-
ase activation only slightly decreased in NLRP3(1434/1113)
MutB reporter (Fig. 4). In contrast, mutation in both NF-jB binding
sequences signiﬁcantly attenuated LPS-induced luciferase activa-
tion, indicating these two NF-jB binding sites are required for
LPS-induced NLRP3 expression (Fig. 4). All together, these data
indicate that the two NF-jB binding sites in the NLRP3 promoter
region from nt 1434 to 1113 are responsible for LPS-induced
NLRP3 expression.
3.5. LPS induces NF-jB binding to NLRP3 promoter
In order to investigate NF-jB binding to NLRP3 promoter, EMSA
was performed using a biotin-labeled 30-nt fragment (nt 1313 to
1284) containing the NF-jB binding site A of the NLRP3 pro-
moter. As shown in Fig. 5A, nuclear proteins from LPS-stimulated
Fig. 3. Characterization of NLRP3 promoter. (A) RAW264.7 macrophages were transfected with the luciferase reporters with different length of NLRP3 promoter fragment
together with pTK-Renilla luciferase plasmid. Twenty-four hours later, the cells were stimulated with 100 ng/ml LPS for 8 h and luciferase activity was measured and
normalized by Renilla luciferase activity. Data are shown as ±S.D. (n = 6) of one representative experiment. (⁄, P < 0.05 versus control). (B) RAW264.7 macrophages were
transfected with NLRP3(2032/1434) or NLRP3(1434/1113) luciferase reporters together with pTK-Renilla luciferase plasmid. Twenty-four hours later, the cells were
stimulated with 100 ng/ml LPS for 8 h and luciferase activity was measured and normalized by Renilla luciferase activity. Data are shown as ±S.D. (n = 6) of one representative
experiment. (⁄, P < 0.05 versus NLRP3(2034/1434) and pGL3).
Fig. 4. Identiﬁcation of NF-jB binding sites in the NLRP3 promoter. RAW264.7
macrophages were transfected with NLRP3(1434/1113) WT, NLRP3(1434/
1113) MutA, NLRP3(1434/1113) MutB or NLRP3(1434/1113) MutAB lucif-
erase reporters together with pTK-Renilla luciferase plasmid. Twenty-four hours
later, the cells were stimulated with 100 ng/ml LPS for 8 h and luciferase activity
was measured and normalized by Renilla luciferase activity. Data are shown as
±S.D. (n = 6) of one representative experiment (⁄, P < 0.05 versus WT, MutA and
MutB).
Fig. 5. LPS induces NF-jB binding to the NLRP3 promoter. (A) Peritoneal macro-
phages were stimulated with LPS (100 ng/ml) for 1 h. Then, nuclear extracts were
prepared and EMSA was performed with the biotin-labeled NLRP3 oligonucleotides
containing NF-jB binding site A. In competitive binding assays, non-competitive
binding assays and supershift assays, unlabeled NLRP3 oligonucleotides, unlabeled
EBNA oligonucleotides and NF-jB p65 antibody were added to the above reactions.
(B) Peritoneal macrophages were stimulated with LPS (100 ng/ml) or vehicle for
1.5 h, ChIP assays were performed to assess the binding of p65 to the NF-jB binding
sites in the nt 1348 to 1183 region of the murine NLRP3 promoter. Total extract
was used as a loading control (input), and immunoprecipitation with irrelevant
antibody (anti-actin) was used as a negative control. Similar results were obtained
in three independent experiments.
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This binding was competed by unlabeled speciﬁc probes (lane 3),
but not by unlabeled non-speciﬁc probes (lane 4). Importantly,
incubation with NF-jB p65 antibody supershifted the DNA:protein
complex (lane 5), indicating the speciﬁcity of NF-jB binding. To
further conﬁrm the interaction between NF-jB and NLRP3 pro-
moter in vivo, CHIP assays were performed (Fig. 5B). In unstimu-
lated macrophages, both anti-actin antibody and anti-p65
antibody did not exhibit speciﬁc immunoprecipitation of NLRP3
promoter fragment (lane 1 and 2), whereas in LPS-stimulated mac-
rophages reactions containing antibody against p65 demonstratedspeciﬁc binding of selected portion of NLRP3 promoter (lane 4),
compared to the reactions containing antibody against actin (lane
3). These results demonstrate that NF-jB directly binds to the NF-
jB binding sites of the NLRP3 promoter in LPS-stimulated
macrophages.
1026 Y. Qiao et al. / FEBS Letters 586 (2012) 1022–10264. Discussion
The NLRP3 inﬂammasome is a pivotal platform for the sensing
of endogenous and exogenous danger signals and for the subse-
quent orchestration of inﬂammatory response. However, the regu-
latory mechanisms for NLRP3 transcription are poorly understood.
In this regard, TLR signaling has been reported to induce NLRP3
expression in primary human monocytes [13–15]. Consistent with
these ﬁndings, we found TLR agonists LPS and PGN could induce
NLRP3 expression in both RAW264.7 macrophages and primary
peritoneal macrophages. Thus, TLR-induced NLRP3 expression in
macrophage/monocytes provided an excellent system to investi-
gate the molecular mechanisms involved in the regulation of
NLRP3 expression.
TLR signaling in macrophages leads to the activation of several
transcription factors including NF-jB and AP-1 [10]. Using a NF-jB
activation inhibitor JSH-23, we found LPS- and PGN-induced NLRP3
expression is dependent on the activation of NF-jB. Clonal deletion
analysis of NLRP3 promoter-luciferase constructs mapped the cis-
regulatory elements involved in LPS-induced NLRP3 expression
to a region from nt 1434 to 1113. There are two putative NF-
jB binding sites in this region predicted with TRANSFAC 6.0 pro-
gram. Single and double point mutations of the NF-jB binding sites
indicate both of NF-jB binding sites are involved in LPS-induced
regulation of NLRP3 transcription. Furthermore, NF-jB binding to
these sequences was conﬁrmed with EMSA and ChIP experiments.
Thus, TLR-induced NF-jB activation is involved in the regulation of
NLRP3 transcription through binding to the conserved NF-jB bind-
ing sites in the NLRP3 promoter. Another transcription factor AP-1
is activated by various MAP kinases in TLR signaling. Using various
MAP kinases inhibitors, we found AP-1 is also involved in the reg-
ulation of NLRP3 expression (data not shown). Therefore, the pre-
cise mechanism for the regulation of NLRP3 expression needs
further investigation.
Toll-like receptors (TLR) and the nucleotide binding domain
(NOD)-like receptors (NLR) are two important kinds of pattern
recognition receptors (PRRs) [16]. TLRs detect extracellular and
intracellular vacuolar stimuli, while NLRs appear to respond to
cytosolic stimuli. Recent studies have conﬁrmed that crosstalking
between TLR signaling and NLR signaling is essential for the ﬁne
regulation of the immune responses [17]. For instance, both TLRs
and NLRs are required for IL-1b secretion. TLR signaling induced
the expression of the 35 kDa pro-IL-1b [18], while maturation
and secretion of 17 kDa IL-1b needs the activation of NLR inﬂam-
masome [19–22]. In this report, we demonstrated that TLR ago-
nists could induce the expression of NLRP3 transcription.
Therefore, TLR-induced NLRP3 expression represents another
example of the crosstalking between TLR and NLR signaling.
In conclusion, we demonstrated transcription factor NF-jB is
involved in the regulation of NLRP3 transcription in TLR-stimu-
lated macrophages through binding to the NF-jB sequences in
the NLRP3 promoter. Given the pathological role of NLRP3 in
numerous inﬂammatory diseases, our ﬁndings may provide some
clues to treat these inﬂammatory diseases.Acknowledgements
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